CAPiTA
Related
Metabolic dysfunction associated steatotic liver disease and the heart
Commentary by Dr. Marco Alings, MD PhD, Amphia Ziekenhuis, Breda; WCN, Utrecht; Scientific Officer at Julius ClinicalThe estimated prevalence of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in the adult population is 31% ...
GRIPonMASH received significant EU funding to improve prevention and care of Metabolic dysfunction-Associated SteatoHepatitis (MASH)
Utrecht, The Netherlands, 05-02-2024GRIPonMASH, a newly founded consortium consisting of 27 European institutions and companies, has bundled resources to bring about a transformational change in the detection and treatment of Metabolic Dysfunc...
Upcoming webinar – Getting GRIP on MASH after LITMUS
On March 12th, we will organise the webinar: Getting GRIP on MASH after LITMUSDuring this webinar, our speaker and hosts will dive into the following topics:The usefulness of noninvasive diagnostic methods depends on the prevalence of t...